Skip to main content

Expanding Our Reach. Strengthening Our Impact.
LGDA is now the Lymphatic Malformations Alliance. Discover the next chapter of our mission. 

Researchers/Clinicians

Update on PIK3CA Inhibitor

Update on PIK3CA Inhibitor (Alpelisib) in Lymphatic Anomalies

Guillaume Canaud, MD, PhD – Necker Hospital, University of Paris (France) 

Be Part of What Comes Next

Together, patients, families, clinicians, and researchers are changing the future of lymphatic malformations. 

Your donation helps make that progress possible.

MENU CLOSE